Company Research Report: Neuranix Srl

Company Overview

Name

Neuranix Srl

Mission

Neuranix aims to radically simplify the evaluation of the middle ear allowing for an objective, quick, and painless assessment, suitable even for pediatric or sensitive patients and those who have undergone ear surgery. Their goal is to improve access to care for the 700 million people who suffer from acute middle ear infections annually (World Health Organization, 2021).

Founded

Neuranix was founded in March 2017.

Founder

The company was founded by Filip E.A. Moens.

Key People

Filip E.A. Moens, Founder, and CEO

Headquarters

Via Taliercio 7/A, 30037 Gardigiano di Scorzè, (VE) Italy

Additional Locations

Contrada Contarini 12, 33057 Palmanova (UD) Italy

Via Coroglio 57, 80124 Napoli, Italy

Number of Employees

No information is available.

Revenue

No information is available.

Known For

Neuranix is known for developing innovative diagnostic devices for middle ear pathologies and transforming conventional diagnostic methods into open, more accessible techniques. It has introduced pioneering technologies including med·wave®, based on the patented PLAI® (Pressure-Less Acoustic Immittance) methodology.

Products

med·wave®

High-Level Description: med·wave® is the first OPEN diagnostic device for evaluating the middle ear, utilizing PLAI® technology. It offers a non-invasive, objective, and quick assessment.

Key Features:

Utilizes patented PLAI® methodology.

Applies no pressure in the ear canal, reducing discomfort.

Capable of assessing a wide range of frequencies to analyze middle ear and tympanum functions.

Certified with MDR CE Certification.

vet·wave®

High-Level Description: The specific features and description are not detailed.

Key Features: No information is available.

Recent Developments

New Product Launches

Approval for med·wave® testing on patients younger than 24 months in PASS/REFER mode as of 2024.

New Features

Significant software update on med·wave® enhancing speed and reactivity.

Partnerships

Collaboration with DP Medical Systems for exclusive distribution of med·wave® in the UK and Ireland.

Partnership with Mack Medizintechnik GmbH for distribution in Germany.

Partnership with SCR ELECTRONIQUES for distribution in France.

Certifications

Awarded the ISO 13485:2016 and ISO 9001:2015 certifications in 2024.

Achieved CE certification for med·wave® (MDR - Medical Device Regulation compliance).

Industry Events

Participated in the 68th EUHA Industry Exhibition and Congress in Hanover, 2024.

Presented at WCA 2024 – 36th World Congress of Audiology in Paris.

Active presence at the 109th Congresso Nazionale SIO in Milan, 2023.

Research and Development

Completed multiple clinical trial phases, validating the innovative approach of med·wave®.

Announced the start of third-phase clinical trials to explore additional functionalities of PLAI® technology.

Funding

Successful completion of a new capital infusion to strengthen the shareholder structure following intense R&D activities.

For more detailed information on products, research advancements, or commercial partnerships, please refer to the company’s official communication channels or contact them directly at info@neuranix.com.